Brown and Leavens said more research is needed to explore factors behind the lower prescription rate for GLP-1s among smokers, but they noted that there are a few potential explanations
Deng, Y., Park, A., Zhu, L., Xie, W., & Pan, C
Liraglutide, marketed under the brand name Saxenda (Novo Nordisk), has demonstrated significant benefits in glycemic control, weight loss, and cardiovascular outcomes in diabetic patients [2]
121 ScaliseM.PochiniL.GiangregorioN.TonazziA.IndiveriC
Efectos adversos y consideraciones de seguridad 1) Efectos adversos ms frecuentes Los efectos secundarios ms habituales son de tipo gastrointestinal: Nuseas Vmitos Diarrea Estreimiento Dolor abdominal Estos sntomas suelen aparecer al inicio del tratamiento o durante los ajustes de dosis y, con frecuencia, disminuyen con el tiempo